Mercer Global Advisors
GLSI icon

Mercer Global Advisors’s Greenwich LifeSciences GLSI Stock Holding History

Mercer Global Advisors’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69K Buy
+72
New +$1.75K ﹤0.01% 5625

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Mercer Global Advisors's GLSI Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Greenwich LifeSciences (GLSI) in Q2 2026: 72 shares worth $1.69K. The stake represents ﹤0.01% of the portfolio and ranks #5625 among its holdings.

43 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Mercer Global Advisors held 72 shares of Greenwich LifeSciences worth $1.69K as of Q2 2026.
  • Greenwich LifeSciences was a new Mercer Global Advisors position in Q2 2026.
  • Greenwich LifeSciences made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5625 holding.
  • 43 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.